Wi J, et al. - In this work, researchers developed a population pharmacokinetics (PK) model for teicoplanin, investigated covariates influencing teicoplanin exposure, and suggested an optimal dosing regimen for extracorporeal membrane oxygenation (ECMO) patients. Findings suggested the necessity for doses higher than the standard doses to achieve fast and appropriate teicoplanin exposure during ECMO.